Biotech Stock Edesa Biotech (Nasdaq:EDSA) Gains on News of Additional Positive Results from Phase 3 Paridiprubart Study

(Investorideas.com Newswire) a go-to platform for big investing ideas, including  biotech stocks issues a news and trading alert for Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases. The stock makes the Nasdaq top gainer list on news today, currently trading at $1.5300, up 0.6310 on over 38 Million shares as of this report. The stock has a morning  high of $1.60. Edesa Biotech announced today p ...